External broker reports(aggregated public sources), CMB International

CMB International

External broker reports(aggregated public sources)

Incorporated in Hong Kong, supported by the mainland and targeting in global market, CMB International Capital Corporation Limited (“CMBI”) is an integrated financial institution providing comprehensive and professional services. As a wholly-owned subsidiary of China Merchants Bank ("CMB"), by leveraging on the Group’s synergy and coordination in domestic and overseas markets, as well as CMB’s strong resources and outstanding social reputation, CMBI and its subsidiaries have been actively implementing diversified business strategies and set up an overall layout of main business segments including Corporate Finance, Asset Management, Wealth Management, Global Markets and Structured Finance, etc. Adhering to the philosophy of “being clients oriented and increasing our own values by the way of creating value for clients”, CMBI endeavors to provide quality and integrated financial services to institutional, corporate and individual customers both domestic and overseas including Hong Kong IPO sponsorship and underwriting, share placement and rights issue for listed companies, financial advisors, bonds issuance services, asset management, direct investment, wealth management, equity sales and trading, etc.

Equity Bottom-Up

<ul><li>Standardizing medical imaging data is pivotal for advancing AI-driven healthcare solutions.</li><li>Current limitations in healthcare AI development stem from insufficient high-quality datasets.</li><li>China has been accelerating nationwide sharing of medical imaging data.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Standardizing medical imaging data is pivotal for advancing AI-driven healthcare solutions.Current limitations in healthcare AI development stem from insufficient high-quality datasets.China has been accelerating nationwide sharing of medical imaging data.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Rimag Group (2522 HK) - Medical Imaging Data Standardization Empowers AI Applications

<ul><li>Rimag leads in the third-party medical imaging services market in China.</li><li>According to Frost &amp; Sullivan (F&amp;S), the Company was the largest medical group specialized in medical imaging in China in 2023 in terms of medical imaging centers, equipment units, registrations by practicing radiologists who registered the Company as their primary workplace, average daily screening volume, and patient fees.</li><li>With a large population, China has a rapidly expanding market for medical imaging services. According to F&amp;S, China’s medical imaging service market is expected to grow at a CAGR of 13.6% from RMB270.9bn in 2023 to RMB661.5bn in 2030E.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Rimag leads in the third-party medical imaging services market in China.According to Frost &amp; Sullivan (F&amp;S), the Company was the largest medical group specialized in medical imaging in China in 2023 in terms of medical imaging centers, equipment units, registrations by practicing radiologists who registered the Company as their primary workplace, average daily screening volume, and patient fees.With a large population, China has a rapidly expanding market for medical imaging services. According to F&amp;S, China’s medical imaging service market is expected to grow at a CAGR of 13.6% from RMB270.9bn in 2023 to RMB661.5bn in 2030E.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Rimag Group (2522 HK) - A Leading Medical Imaging Service Provider in China

China

Jiangxi Rimag Group Co., Ltd. is a medical group specializing in medical imaging in China. It provides imaging center services, imaging solution services, and digital-intelligence services, including examination and diagnostic services like MRI and CT, equipment solutions for hospitals, and cloud-based medical imaging platforms. The company was founded in 2014 and is headquartered in Beijing, China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jiangxi Rimag (2522 HK)

Rimag Group (2522 HK) - Medical Imaging Data Standardization Empowers AI Applications

Standardizing medical imaging data is pivotal for advancing AI-driven healthcare solutions. Current limitations in healthcare AI development stem...

CMB International

Rimag Group (2522 HK) - A Leading Medical Imaging Service Provider in China

According to Frost & Sullivan (F&S), the Company was the largest medical group specialized in medical imaging in China in 2023 in terms of medical...

CMB International

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)